Dr. Fred Lublin: “New Medications for Multiple Sclerosis”
The MD Magazine Peer Exchange "Modifying the Course of Multiple Sclerosis in New Ways: The Latest Advances in Treatment" features a distinguished panel of physician experts discussing key topics in multiple sclerosis (MS) research and management, including the latest insights into MS pathophysiology, new medication options and their application in clinical practice, and more. One physician on the panel was Fred D. Lublin, MD, of the Icahn School of Medicine at Mount Sinai. He noted that noted that comparative efficacy data has shown that the new oral agents are at least as effective and in some cases more effective than the therapies that preceded them. Learn more
New Study Details The Various Ways Patients with Multiple Sclerosis Develop Impairment
Feb 22, 2022 View All Press Releases
Two Mount Sinai Experts Receive Honors From the National Multiple Sclerosis Society
Sep 16, 2021 View All Press Releases